Spinal Manipulation Therapy (SMT) for Chronic Lower Back Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Rush University Medical Center, Chicago, ILChronic Lower Back PainSpinal Manipulation Therapy (SMT) - Other
Eligibility
18 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial will aim to test the effectiveness of mindfulness therapy and spinal manipulation therapy in reducing the need for chronic high-dose opioids by measuring changes in endogenous opioid function.

Eligible Conditions
  • Chronic Lower Back Pain

Treatment Effectiveness

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Baseline, after each weekly treatment session, 3- and 6-month follow-up (roughly 16 weeks)

Week 16
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Depression
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity (Short Form)
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (Short Form)
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance

Trial Safety

Trial Design

2 Treatment Groups

SMT plus placebo/naloxone
1 of 2
MT plus placebo/naloxone
1 of 2

Experimental Treatment

240 Total Participants · 2 Treatment Groups

Primary Treatment: Spinal Manipulation Therapy (SMT) · Has Placebo Group · Phase < 1

SMT plus placebo/naloxoneExperimental Group · 3 Interventions: Spinal Manipulation Therapy (SMT), Naloxone, Placebo · Intervention Types: Other, Drug, Drug
MT plus placebo/naloxoneExperimental Group · 3 Interventions: Naloxone, Placebo, Mindfulness Based Stress Reduction Therapy (MT) · Intervention Types: Drug, Drug, Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Naloxone
FDA approved
Placebo
1995
Completed Phase 3
~2640

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, after each weekly treatment session, 3- and 6-month follow-up (roughly 16 weeks)

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
391 Previous Clinical Trials
153,397 Total Patients Enrolled
Vanderbilt University Medical CenterOTHER
784 Previous Clinical Trials
599,088 Total Patients Enrolled
John Burns, PhDPrincipal InvestigatorRush University Medical Center
Stephen Bruehl, PhDPrincipal InvestigatorVanderbilt University Medical Center
2 Previous Clinical Trials
237 Total Patients Enrolled

Eligibility Criteria

Age 18 - 75 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been experiencing daily chronic pain that is at least 4 out of 10 on a pain scale and it has been affecting your ability to do daily activities for at least 3 months.
References

Frequently Asked Questions

Are there any existing reports of research involving Naloxone?

"Presently, 38 clinical trials examining the efficacy of Naloxone are active globally with 9 in their final stage. While the majority of them occur in Durham, North Carolina, a total of 119 sites have been operating studies for this drug." - Anonymous Online Contributor

Unverified Answer

How many participants are taking part in the investigation?

"Affirmative. According to clinicaltrials.gov, this clinical trial is actively looking for participants; the study was initially published on August 10th 2020 and has been recently updated on November 22nd 2022. It aims to recruit 240 individuals from 2 separate locations." - Anonymous Online Contributor

Unverified Answer

Are applicants aged 45 or above eligible for inclusion in this medical trial?

"This medical trial is only open to participants aged 18 - 75. However, there are 15 trials for minors and 293 studies that cater to individuals above the age of 65." - Anonymous Online Contributor

Unverified Answer

Are there any openings for new participants in this clinical trial?

"Affirmative. Clinicaltrials.gov offers evidence that this medical study, which initially went live on August 10th 2020, is currently enrolling participants. The research necessitates the recruitment of 240 individuals from two distinct locations." - Anonymous Online Contributor

Unverified Answer

What kinds of conditions does Naloxone treat most frequently?

"In addition to treating opioid overdose, Naloxone can be used therapeutically on patients presenting with pain, itching and septic shock." - Anonymous Online Contributor

Unverified Answer

Do I conform to the criteria necessary for participation in this experiment?

"This medical trial seeks to enroll 240 individuals between the ages of 18 and 75 who experience chronic low [back pain](https://www.withpower.com/clinical-trials/back-pain). To be considered, participants must exhibit a minimum daily intensity level of 4 out 10 on the pain scale as well as 3 or more points of interference in their everyday activities for at least three months. Furthermore, they need not use opioid analgesics within 72 hours of each laboratory session (evidenced by drug screening), possess intact cognitive functioning and demonstrate proficiency with English reading and writing sufficient enough to comprehend study questionnaires and provide informed consent." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.